New advances in CMV and immunosenescence

Experimental Gerontology

Volumn 55, Issue , 2014, Pages 54-62

  Sansoni, Paolo ^a   Vescovini, Rosanna ^a   Fagnoni, Francesco F ^b   Akbar, Arne ^c   Arens, Ramon ^d   Chiu, Yen Ling ^e   Čičin Šain, Luka ^f   Dechanet Merville, Julie ^g   Derhovanessian, Evelyna ^h   Ferrando Martinez, Sara ^i,j   Franceschi, Claudio ^k   Frasca, Daniela ^l   Fulöp, Tamas ^m   Furman, David ^g,n   Gkrania Klotsas, Effrossyni ^o   Goodrum, Felicia ^p   Grubeck Loebenstein, Beatrix ^q   Hurme, Mikko ^r   Kern, Florian ^s   Lilleri, Daniele ^t   López Botet, Miguel ^u   Maier, Andrea B ^v   Marandu, Thomas ^f   Marchant, Arnaud ^w   Matheï, Catharina ^x   Moss, Paul ^y   Muntasell, Aura ^a   Remmerswaal, Ester B M ^z   Riddell, Natalie E ^c   Rothe, Kathrin ^aa   Sauce, Delphine ^ab   Shin, Eui Cheol ^ac   Simanek, Amanda M ^ad   Smithey, Megan J ^p   Söderberg Nauclér, Cecilia ^ae   Solana, Rafael ^af   Thomas, Paul G ^ag   Van Lier, Rene ^ah   Pawelec, Graham ^h   Nikolich Zugich, Janko ^p   more..

^a UNIVERSITY OF PARMA   (Italy)

^b Immunohematology and Transfusion Center   (Italy)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^g CNRS Bordeaux Segalen University   (France)

^h UNIVERSITY OF TÜBINGEN   (Germany)

ⁱ HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^j BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^k UNIVERSITY OF BOLOGNA   (Italy)

^l UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^m UNIVERSITÉ DE SHERBROOKE   (Canada)

ⁿ STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^p UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^q UNIVERSITY OF INNSBRUCK   (Austria)

^r TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^s BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^t FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^u UNIVERSITAT POMPEU FABRA   (Spain)

^v VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^w UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^x UNIVERSITY OF LEUVEN   (Belgium)

^y UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^z Department of Experimental Immunology and Renal Transplant Unit Department of Internal Medicine ^*  (Netherlands)

^aa UNIVERSITY OF LEIPZIG   (Germany)

^ab INSERM   (France)

^ac Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^ad UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^ae KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^af UNIVERSITY OF CÓRDOBA   (Spain)

^ag ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^ah CENTRAL LABORATORY   (Netherlands)

more..

Author keywords

Cytomegalovirus infection; Immune homeostasis; Immunosenescence; Pathologies of aging; Virus host interaction

Indexed keywords

AGING; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; PHYSIOLOGY; VIROLOGY; VIRUS LATENCY;

AGING; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; VIRUS LATENCY;

EID: 84898883473     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2014.03.020     Document Type: Article

References (30)

1. Barton E.S., White D.W., Cathelyn J.S., Brett-McClellan K.A., Engle M., Diamond M.S., Miller V.L., Virgin H.W.t Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 2007, 447:326-329.
2. Bughio F., Elliott D.A., Goodrum F. An endothelial cell-specific requirement for the UL133-UL138 locus of human cytomegalovirus for efficient virus maturation. J. Virol. 2013, 87:3062-3075.
3. Cicin-Sain L., Brien J.D., Uhrlaub J.L., Drabig A., Marandu T.F., Nikolich-Zugich J. Cytomegalovirus infection impairs immune responses and accentuates T-cell pool changes observed in mice with aging. PLoS Pathog. 2012, 8:e1002849.
4. Derhovanessian E., Maier A.B., Hahnel K., Zelba H., de Craen A.J., Roelofs H., Slagboom E.P., Westendorp R.G., Pawelec G. Lower proportion of naive peripheral CD8+ T cells and an unopposed pro-inflammatory response to human Cytomegalovirus proteins in vitro are associated with longer survival in very elderly people. Age (Dordr) 2013, 35:1387-1399.
5. Gow A.J., Firth C.M., Harrison R., Starr J.M., Moss P., Deary I.J. Cytomegalovirus infection and cognitive abilities in old age. Neurobiol. Aging 2013, 34:1846-1852.
6. Griffiths S.J., Riddell N.E., Masters J., Libri V., Henson S.M., Wertheimer A., Wallace D., Sims S., Rivino L., Larbi A., Kemeny D.M., Nikolich-Zugich J., Kern F., Klenerman P., Emery V.C., Akbar A.N. Age-associated increase of low-avidity cytomegalovirus-specific CD8+ T cells that re-express CD45RA. J. Immunol. 2013, 190:5363-5372.
7. Hertoghs K.M., Moerland P.D., van Stijn A., Remmerswaal E.B., Yong S.L., van de Berg P.J., van Ham S.M., Baas F., ten Berge I.J., van Lier R.A. Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation. J. Clin. Invest. 2010, 120:4077-4090.
8. Kuparinen T., Marttila S., Jylhava J., Tserel L., Peterson P., Jylha M., Hervonen A., Hurme M. Cytomegalovirus (CMV)-dependent and -independent changes in the aging of the human immune system: a transcriptomic analysis. Exp. Gerontol. 2013, 48:305-312.
9. Lozza L., Lilleri D., Percivalle E., Fornara C., Comolli G., Revello M.G., Gerna G. Simultaneous quantification of human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells by a novel method using monocyte-derived HCMV-infected immature dendritic cells. Eur. J. Immunol. 2005, 35:1795-1804.
10. Mekker A., Tchang V.S., Haeberli L., Oxenius A., Trkola A., Karrer U. Immune senescence: relative contributions of age and cytomegalovirus infection. PLoS Pathog. 2012, 8:e1002850.
11. Muntasell A., Vilches C., Angulo A., Lopez-Botet M. Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction. Eur. J. Immunol. 2013, 43:1133-1141.
12. Pawelec G., Akbar A., Beverley P., Caruso C., Derhovanessian E., Fulop T., Griffiths P., Grubeck-Loebenstein B., Hamprecht K., Jahn G., Kern F., Koch S.D., Larbi A., Maier A.B., Macallan D., Moss P., Samson S., Strindhall J., Trannoy E., Wills M. Immunosenescence and Cytomegalovirus: where do we stand after a decade?. Immun. Ageing 2010, 7:13.
13. Rahbar A., Orrego A., Peredo I., Dzabic M., Wolmer-Solberg N., Straat K., Stragliotto G., Soderberg-Naucler C. Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival. J. Clin. Virol. 2013, 57:36-42.
14. Remmerswaal E.B., Havenith S.H., Idu M.M., van Leeuwen E.M., van Donselaar K.A., Ten Brinke A., van der Bom-Baylon N., Bemelman F.J., van Lier R.A., Ten Berge I.J. Human virus-specific effector-type T cells accumulate in blood but not in lymph nodes. Blood 2012, 119:1702-1712.
15. Roux A., Mourin G., Larsen M., Fastenackels S., Urrutia A., Gorochov G., Autran B., Donner C., Sidi D., Sibony-Prat J., Marchant A., Stern M., Sauce D., Appay V. Differential impact of age and cytomegalovirus infection on the gammadelta T cell compartment. J. Immunol. 2013, 191:1300-1306.
16. Savva G.M., Pachnio A., Kaul B., Morgan K., Huppert F.A., Brayne C., Moss P.A. Cytomegalovirus infection is associated with increased mortality in the older population. Aging Cell 2013, 12:381-387.
17. Smithey M.J., Li G., Venturi V., Davenport M.P., Nikolich-Zugich J. Lifelong persistent viral infection alters the naive T cell pool, impairing CD8 T cell immunity in late life. J. Immunol. 2012, 189:5356-5366.
18. Solana R., Tarazona R., Aiello A.E., Akbar A.N., Appay V., Beswick M., Bosch J.A., Campos C., Cantisan S., Cicin-Sain L., Derhovanessian E., Ferrando-Martinez S., Frasca D., Fulop T., Govind S., Grubeck-Loebenstein B., Hill A., Hurme M., Kern F., Larbi A., Lopez-Botet M., Maier A.B., McElhaney J.E., Moss P., Naumova E., Nikolich-Zugich J., Pera A., Rector J.L., Riddell N., Sanchez-Correa B., Sansoni P., Sauce D., van Lier R., Wang G.C., Wills M.R., Zielinski M., Pawelec G. CMV and Immunosenescence: from basics to clinics. Immun. Ageing 2012, 9:23.
19. Stragliotto G., Rahbar A., Solberg N.W., Lilja A., Taher C., Orrego A., Bjurman B., Tammik C., Skarman P., Peredo I., Soderberg-Naucler C. Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study. Int. J. Cancer 2013, 133:1204-1213.
20. Strandberg T.E., Pitkala K.H., Tilvis R.S. Cytomegalovirus antibody level and mortality among community-dwelling older adults with stable cardiovascular disease. JAMA 2009, 301:380-382.
21. Sylwester A.W., Mitchell B.L., Edgar J.B., Taormina C., Pelte C., Ruchti F., Sleath P.R., Grabstein K.H., Hosken N.A., Kern F., Nelson J.A., Picker L.J. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 2005, 202:673-685.
22. Terrazzini N., Bajwa M., Vita S., Cheek E., Thomas D., Seddiki N., Smith H., Kern F. A novel CMV-induced regulatory type T-cell subset increases in older life and links virus-specific immunity to vascular pathology. J. Infect. Dis. 2013, (Dec 9, Epub ahead of print).
23. Umashankar M., Ralk M., Bughio F., Zagallo P., Caviness K., Goodrum F. Antagonistic determinants controlling replicative and latent states of human cytomegaovirus infection. J Virol. 2014, (Mar 12, Epub ahead of print).
24. Vaes B., Pasquet A., Wallemacq P., Rezzoug N., Mekouar H., Olivier P.A., Legrand D., Mathei C., Van Pottelbergh G., Degryse J. The BELFRAIL (BFC80+) study: a population-based prospective cohort study of the very elderly in Belgium. BMC Geriatr. 2010, 10:39.
25. Wall N.A., Chue C.D., Edwards N.C., Pankhurst T., Harper L., Steeds R.P., Lauder S., Townend J.N., Moss P., Ferro C.J. Cytomegalovirus seropositivity is associated with increased arterial stiffness in patients with chronic kidney disease. PLoS ONE 2013, 8:e55686.
26. Wang G.C., Kao W.H., Murakami P., Xue Q.L., Chiou R.B., Detrick B., McDyer J.F., Semba R.D., Casolaro V., Walston J.D., Fried L.P. Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study. Am. J. Epidemiol. 2010, 171:1144-1152.
27. Welzl K., Weinberger B., Kronbichler A., Sturm G., Kern G., Mayer G., Grubeck-Loebenstein B., Koppelstaetter C. How immunosuppressive therapy affects T cells from kidney transplanted patients of different age: the role of latent CMV infection. Clin. Exp. Immunol. 2014, 176:112-119.
28. Willcox C.R., Pitard V., Netzer S., Couzi L., Salim M., Silberzahn T., Moreau J.F., Hayday A.C., Willcox B.E., Dechanet-Merville J. Cytomegalovirus and tumor stress surveillance by binding of a human gammadelta T cell antigen receptor to endothelial protein C receptor. Nat. Immunol. 2012, 13:872-879.
29. Wills M., Akbar A., Beswick M., Bosch J.A., Caruso C., Colonna-Romano G., Dutta A., Franceschi C., Fulop T., Gkrania-Klotsas E., Goronzy J., Griffiths S.J., Henson S., Herndler-Brandstetter D., Hill A., Kern F., Klenerman P., Macallan D., Macualay R., Maier A.B., Mason G., Melzer D., Morgan M., Moss P., Nikolich-Zugich J., Pachnio A., Riddell N., Roberts R., Sansoni P., Sauce D., Sinclair J., Solana R., Strindhall J., Trzonkowski P., van Lier R., Vescovini R., Wang G., Westendorp R., Pawelec G. Report from the second cytomegalovirus and immunosenescence workshop. Immun. Ageing 2011, 8:10.
30. Wolmer-Solberg N., Baryawno N., Rahbar A., Fuchs D., Odeberg J., Taher C., Wilhelmi V., Milosevic J., Mohammad A.A., Martinsson T., Sveinbjornsson B., Johnsen J.I., Kogner P., Soderberg-Naucler C. Frequent detection of human cytomegalovirus in neuroblastoma: a novel therapeutic target?. Int. J. Cancer. 2013, 133:2351-2361.